[1]续斌,杨燕,高健,等.黄芩素调控SLC7A11/GPX4信号通路改善铁死亡促进骨髓间充质干细胞成骨分化实验研究[J].陕西医学杂志,2026,(6):761-768.[doi:DOI:10.3969/j.issn.1000-7377.2026.06.007]
 XU Bin,YANG Yan,GAO Jian,et al.Baicalein regulating SLC7A11/GPX4 signaling pathway to improve ferroptosis and promote osteogenic differentiation of BMSCs[J].,2026,(6):761-768.[doi:DOI:10.3969/j.issn.1000-7377.2026.06.007]
点击复制

黄芩素调控SLC7A11/GPX4信号通路改善铁死亡促进骨髓间充质干细胞成骨分化实验研究

《陕西医学杂志》[ISSN:1000-7377/CN:61-1281/TN]

卷:
期数:
2026年6期
页码:
761-768
栏目:
基础研究
出版日期:
2026-06-05

文章信息/Info

Title:
Baicalein regulating SLC7A11/GPX4 signaling pathway to improve ferroptosis and promote osteogenic differentiation of BMSCs
作者:
续斌杨燕高健柴浩王国胜
(新疆医科大学第六附属医院创伤二科,新疆 乌鲁木齐 830000)
Author(s):
XU BinYANG YanGAO JianCHAI HaoWANG Guosheng
(The Second Department of Trauma,Sixth Affiliated Hospital of Xinjiang Medical University,Urumqi 830000,China)
关键词:
骨质疏松骨髓间充质干细胞黄芩素铁死亡溶质载体家族7成员11/谷胱甘肽过氧化物酶4通路成骨分化
Keywords:
OsteoporosisBone marrow mesenchymal stem cellsBaicaleinFerroptosisSLC7A11/GPX4 pathwayOsteogenic differentiation
分类号:
R 285.5
DOI:
DOI:10.3969/j.issn.1000-7377.2026.06.007
文献标志码:
A
摘要:
目的:探讨黄芩素(BAI)通过调控溶质载体家族 7 成员11(SLC7A11)/谷胱甘肽过氧化物酶4(GPX4)信号通路抑制骨髓间充质干细胞(BMSCs)铁死亡、促进成骨分化的作用。方法:采用高糖高脂(HGHF)环境联合铁死亡诱导剂 Erastin 构建BMSCs铁死亡及成骨功能受损模型,并给予BAI及铁死亡抑制剂 Ferrostatin-1(Fer-1)干预。实验分为五组:①对照组(正常培养条件);②模型组(HGHF环境);③铁死亡诱导剂组(HGHF+300 μmol/L Erastin);④模型+BAI组(HGHF+20 μmol/L BAI);⑤模型+铁死亡抑制剂组(HGHF+10 μmol/L Fer-1)。采用CCK-8法检测细胞活力;采用透射电镜观察线粒体超微结构变化;应用二氯荧光素(DCFH-DA)探针及相关试剂盒检测活性氧(ROS)、丙二醛(MDA)、谷胱甘肽(GSH)水平;采用茜素红S染色评价矿化结节形成;采用Western blot法检测SLC7A11、GPX4、酰基辅酶A合成酶长链家族成员4(ACSL4)、铁蛋白重链1(FTH1)及成骨相关蛋白Runt相关转录因子2(RUNX2)、Ⅰ型胶原α1链(COL1A1)、骨钙素(OCN)的表达水平。结果:与对照组比较,模型组和铁死亡诱导剂组的BMSCs细胞活力显著降低,线粒体结构出现明显萎缩、膜破裂和嵴减少(均P<0.05)。与模型组和铁死亡诱导剂组比较,模型+BAI组细胞活力明显提高,线粒体结构得到显著改善,细胞内ROS、MDA水平显著降低,GSH水平显著升高(均P<0.05)。同时,BAI干预显著上调SLC7A11、GPX4、FTH1、RUNX2、COL1A1和OCN的蛋白表达,显著下调ACSL4的表达,促进矿化结节的形成(均P<0.05)。这些结果表明,BAI能够有效改善BMSCs的活性和成骨分化能力,其效果与模型+铁死亡抑制剂组相似。结论:BAI可通过激活SLC7A11/GPX4信号通路抑制BMSCs铁死亡,减轻氧化应激损伤,从而恢复其成骨分化能力。
Abstract:
Objective:To investigate the role of Baicalein (BAI) in inhibiting ferroptosis in bone marrow mesenchymal stem cells (BMSCs) and promoting osteogenic differentiation through regulating the solute carrier family 7 member 11 (SLC7A11)/glutathione peroxidase 4 (GPX4) signaling pathway.Methods:A BMSCs ferroptosis and osteogenic dysfunction model was established by using a high-fat,high-glucose (HGHF) environment combined with the ferroptosis inducer Erastin,followed by intervention with BAI and ferroptosis inhibitor Ferrostatin-1 (Fer-1).The experiment was divided into five groups:①Control group (normal culture conditions);②Model group (HGHF environment);③Ferroptosis inducer group (HGHF+300 μmol/L Erastin);④Model+BAI group (HGHF+20 μmol/L BAI);⑤Model+ferroptosis inhibitor group (HGHF+10 μmol/L Fer-1).Cell viability was measured using the CCK-8 assay.Mitochondrial ultrastructure was observed by transmission electron microscopy.Reactive oxygen species (ROS),malondialdehyde (MDA),and glutathione (GSH) levels were assessed using DCFH-DA probes and related kits.Mineralized nodule formation was evaluated by alizarin red S staining;and the expression levels of SLC7A11,GPX4,acyl-CoA synthetase long-chain family member 4 (ACSL4),ferritin heavy chain 1 (FTH1),and osteogenic markers runt-related transcription factor 2 (RUNX2),collagen type Ⅰ alpha 1 chain (COL1A1),and osteocalcin (OCN) were measured by Western blot.Results:Compared with the control group,the BMSCs cell viability in the model group and ferroptosis inducer group was significantly decreased,with obvious mitochondrial shrinkage,membrane rupture,and cristae reduction (all P<0.05).Compared with the model group and the ferroptosis inducer group,the cell viability of the model+BAI group was significantly enhanced,the mitochondrial structure was significantly improved,the intracellular ROS and MDA levels were significantly decreased,and the GSH level was significantly increased (all P<0.05).Meanwhile,BAI intervention significantly upregulated the protein expressions of SLC7A11,GPX4,FTH1,RUNX2,COL1A1 and OCN,significantly downregulated the expression of ACSL4,and promoted the formation of mineralized nodules (all P<0.05).These results indicated that BAI could effectively enhance the activity and osteogenic differentiation ability of BMSCs,and its effect was similar to that of the model+ferroptosis inhibitor group.Conclusion:BAI can inhibit ferroptosis in BMSCs and alleviate oxidative stress injury by activating the SLC7A11/GPX4 signaling pathway,thereby restoring their osteogenic differentiation ability.

参考文献/References:

[1]袁金秋.中国人群骨质疏松症风险管理公众指南(2024)[J].中华骨质疏松和骨矿盐疾病杂志,2024,17(6):533-548.[2]罗红清,邓洁,徐丽,等.杜仲水提取物通过PI3K/AKT途径调节铁代谢改善糖尿病性骨质疏松症实验研究[J].陕西医学杂志,2025,54(12):1608-1615.[3]尹英超,董琪,贾会扬,等.《骨质疏松性骨折诊疗指南(2022)》解读[J].河北医科大学学报,2024,45(8):869-872.[4]史晓林,刘康.老年性骨质疏松症中西医结合诊疗指南[J].中国骨质疏松杂志,2024,30(7):937-946.[5]唐剑,陈双华,何凌.骨髓间充质干细胞来源外泌体对大鼠脊髓损伤的改善作用及对脊髓组织胞浆型磷脂酶A2、水通道蛋白4和水通道蛋白9的影响实验研究[J].陕西医学杂志,2023,52(12):1654-1659.[6]WU J,HU M,JIANG H,et al.Endothelial cell-derived lactate triggers bone mesenchymal stem cell histone lactylation to attenuate osteoporosis[J].Adv Sci (Weinh),2023,10(31):e2301300.[7]YANG Q,ZOU Y,WEI X,et al.PTP1B knockdown alleviates BMSCs senescence via activating AMPK-mediated mitophagy and promotes osteogenesis in senile osteoporosis[J].Biochim Biophys Acta Mol Basis Dis,2023,1869(7):166795.[8]YANG Y,LIN Y,WANG M,et al.Targeting ferroptosis suppresses osteocyte glucolipotoxicity and alleviates diabetic osteoporosis[J].Bone Res,2022,10(1):26.[9]LIU P,ZHANG Z,CAI Y,et al.Ferroptosis:Mechanisms and role in diabetes mellitus and its complications[J].Ageing Res Rev,2024,94:102201.[10]XIA Y,ZHANG H,WANG H,et al.Identification and validation of ferroptosis key genes in bone mesenchymal stromal cells of primary osteoporosis based on bioinformatics analysis[J].Front Endocrinol (Lausanne),2022,13:980867.[11]TANG Z,CHENG L,LI M,et al.Astragaloside Ⅳ alleviates osteoarthritis by inhibiting chondrocyte ferroptosis via the p53/SLC7A11/GPX4 axis[J].J Inflamm Res,2025,18:16169-16186.[12]CHEN X,LIU C,YU R,et al.Interaction between ferroptosis and TNF-α:Impact in obesity-related osteoporosis[J].FASEB J,2023,37(6):e22947.[13]BAI L,WANG T,ZHENG J,et al.SIRT1 mediated by baicalein and GFI1 promotes osteogenic differentiation and ameliorates osteoporosis by inhibiting ferroptosis in bone marrow mesenchymal stem cells[J].J Biochem Mol Toxicol,2025,39(7):e70368.[14]WANG Y,JIANG T.Recent research advances in pain mechanisms in McCune-Albright syndrome thinking about the pain mechanism of FD/MAS[J].J Orthop Surg Res,2024,19(1):196.[15]LI M,TANG Q,LIAO C,et al.Extracellular vesicles from apoptotic BMSCs ameliorate osteoporosis via transporting regenerative signals[J].Theranostics,2024,14(9):3583-3602.[16]LI T,YUAN J,XU P,et al.PMAIP1,a novel diagnostic and potential therapeutic biomarker in osteoporosis[J].Aging (Albany NY),2024,16(4):3694-3715.[17]YOU Y,LIU J,ZHANG L,et al.WTAP-mediated m6A modification modulates bone marrow mesenchymal stem cells differentiation potential and osteoporosis[J].Cell Death Dis,2023,14(1):33.[18]CHEN M,LIANG H,WU M,et al.Fgf9 regulates bone marrow mesenchymal stem cell fate and bone-fat balance in osteoporosis by PI3K/AKT/Hippo and MEK/ERK signaling[J].Int J Biol Sci,2024,20(9):3461-3479.[19]杨伊汨,李冠琼,王巍,等.黄芩苷对根尖周炎大鼠炎症和骨吸收的影响及机制实验研究[J].陕西医学杂志,2025,54(5):584-589.[20]李继凯,陈秀改,李通宪,等.黄芩素调节OPG/RANKL信号通路干预骨质疏松大鼠模型骨密度及铁死亡的作用机制[J].联勤军事医学,2023,37(12):993-997.[21]叶维,张红,王莉,等.汉黄芩素通过调控JNK/AP-1信号通路对缺血性脑卒中大鼠神经功能障碍、脑组织损伤的影响[J].中成药,2023,45(10):3241-3246.[22]曾健,周学东,刘英.黄芩素脂质体通过Nrf2/HO-1/GPX4信号通路诱导铁死亡抑制NSCLC进展[J].解剖科学进展,2025,31(5):602-605,609.[23]朱婷,岳婷婷,崔悦,等.黄芩素可缓解蛛网膜下腔出血后神经元的铁死亡[J].中国组织工程研究,2025,29(1):52-57.[24]楼秀,陈晓红,林志坤,等.基于Nrf2/SLC7A11/GPX4信号通路探讨川芎嗪抑制脑缺血缺氧后神经元铁死亡的作用[J/OL].中国药理学通报,1-13[2025-11-25].https://link.cnki.net/urlid/34.1086.R.20251119.1416.004.[25]DENG X,LIN B,WANG F,et al.Mangiferin attenuates osteoporosis by inhibiting osteoblastic ferroptosis through Keap1/Nrf2/SLC7A11/GPX4 pathway[J].Phytomedicine,2024,124:155282.[26]XU R,WANG W,ZHANG W.Ferroptosis and the bidirectional regulatory factor p53[J].Cell Death Discov,2023,9(1):197.[27]GUO M,ZHUANG Y,WU Y,et al.The cell fate regulator DACH1 modulates ferroptosis through affecting P53/SLC25A37 signaling in fibrotic disease[J].Hepatol Commun,2024,8(3):e0396.

相似文献/References:

[1]郭向东,马 波△.2型糖尿病患者血清胰岛素水平与骨代谢关联研究*[J].陕西医学杂志,2019,(1):77.
 GUO Xiangdong,MA Bo..Association between serum insulin level and bone metabolismin patients with type 2 diabetes mellitus[J].,2019,(6):77.
[2]兰 凯,王让周,钱燕芳,等.胆总管结扎术大鼠血清通过调控AP-2α对骨髓间充质干细胞旁分泌功能影响的实验研究*[J].陕西医学杂志,2019,(6):688.
[3]郭晓昀 ,赵秋艳,刘 娟△ ,等.基于微信公众平台延续康复管理在椎体成形术后的效果观察*[J].陕西医学杂志,2019,(6):715.
[4]李 杰,邱裕生△.骨水泥灌注空心椎弓根螺钉内固定治疗不稳定性胸腰椎骨折合并骨质疏松临床疗效研究[J].陕西医学杂志,2019,(8):1021.
 LI Jie,QIU Yusheng..Polymethylmethacrylate augmented pedicle screw instrumentation fixation combined for osteoporotic thoracolumbar unstable fractures[J].,2019,(6):1021.
[5]王荣锋,郁 昊,蒋新建.老年糖尿病患者血清25羟维生素D水平与骨质疏松相关性研究[J].陕西医学杂志,2019,(8):1032.
 WANG Rongfeng,YU Hao,JIANG Xinjian..The relationship between serum 25 hydroxy vitamin D and osteoporosis in elderly diabetic patients[J].,2019,(6):1032.
[6]王 荣,贾爱华,刘新艳 ,等.IGF1及其相关性因素对2型糖尿病并发骨质疏松的影响研究[J].陕西医学杂志,2019,(9):1163.
 WANG Rong,JIA Aihua,LIU Xinyan,et al.The effect of IGF1 and its related factors in type 2 diabetes complicated with osteoporosis[J].,2019,(6):1163.
[7]李 鹏,佘新安,赵东军,等.骨髓间充质干细胞对大鼠骨质疏松股骨干骨折早期愈合影响的实验研究[J].陕西医学杂志,2021,50(7):793.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.006]
 LI Peng,SHE Xin'an,ZHAO Dongjun,et al.Effect of bone marrow mesenchymal stem cells on early healing of femoral shaft fracture in osteoporotic rats[J].,2021,50(6):793.[doi:DOI:10.3969/j.issn.1000-7377.2021.07.006]
[8]梁朝鑫,周安远,王 伟,等.骨髓间充质干细胞治疗骨科疾病研究进展[J].陕西医学杂志,2022,51(1):121.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.030]
 LIANG Chaoxin,ZHOU Anyuan,WANG Wei,et al.Research progress of bone marrow mesenchymal stem cells in the treatment of orthopedic diseases[J].,2022,51(6):121.[doi:DOI:10.3969/j.issn.1000-7377.2022.01.030]
[9]左 楠,王 远,王 爽.骨髓间充质干细胞移植联合多点微量注射曲安奈德对兔耳增生性瘢痕及创面巨噬细胞极化的影响[J].陕西医学杂志,2022,51(2):140.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.003]
 ZUO Nan,WANG Yuan,WANG Shuang.Effects of bone marrow mesenchymal stem cell transplantation combined with multi-point microinjection of triamcinolone acetonide on hypertrophic scars of rabbit ears and polarization of macrophages in wounds[J].,2022,51(6):140.[doi:DOI:10.3969/j.issn.1000-7377.2022.02.003]
[10]冯 亮,樊 力.骨髓间充质干细胞通过增加血管生成和血管内皮生长因子表达影响大鼠随意型皮瓣存活实验研究[J].陕西医学杂志,2022,51(3):298.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.008]
 FENG Liang,FAN Li.Experimental study of BMSCs on survival of rat random flaps by increasing angiogenesis and VEGF expression[J].,2022,51(6):298.[doi:DOI:10.3969/j.issn.1000-7377.2022.03.008]

备注/Memo

备注/Memo:
新疆维吾尔自治区自然科学基金资助项目(2019D01C246);新疆维吾尔自治区“天山英才”医药卫生高层次人才培养计划(TSYC202301B107)
更新日期/Last Update: 2026-06-05